Skip to main content

U.S. Pharmaceutical Sales - Q3 2012

The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2012. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q3 2012 by Units Sold

Rank Drug Units (000)
1 acetaminophen/hydrocodone
Generic
2.85% Stats
2 budesonide
Generic
-17.22% Stats
3 (1) ProAir HFA
Teva Pharmaceuticals USA, Inc.
8.31% Stats
4 (1) OneTouch
2.38% Stats
5 (1) Nexium
AstraZeneca
4.10% Stats
6 (1) Cymbalta
2.34% Stats
7 (1) Lantus
Sanofi
4.34% Stats
8 (1) Advair Diskus
GlaxoSmithKline
2.47% Stats
9 (2) atorvastatin
Generic
30.20% Stats
10 (4) Lantus Solostar
Sanofi
14.07% Stats
11 (1) Crestor
AstraZeneca
3.89% Stats
12 (1) fentanyl
Generic
0.67% Stats
13 (2) enoxaparin
Generic
-2.35% Stats
14 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
1.34% Stats
15 (1) AndroGel
AbbVie Inc.
-4.66% Stats
16 (3) Novolog
Novo Nordisk
3.53% Stats
17 (3) Levemir
Novo Nordisk
4.30% Stats
18 (4) NovoLog FlexPen
Novo Nordisk
3.28% Stats
19 (16) Singulair
Merck
-62.80% Stats
20 (5) Humalog
Eli Lilly and Company
3.53% Stats
21 (3) Abilify
Otsuka Pharmaceutical Co., Ltd
0.80% Stats
22 (1) metoprolol
Generic
-2.63% Stats
23 (2) Nasonex
Merck
-10.19% Stats
24 (2) Synthroid
AbbVie Inc.
4.96% Stats
25 (2) Januvia
Merck
1.17% Stats
26 (11) escitalopram
Generic
27.33% Stats
27 (2) Namenda
Allergan plc
4.61% Stats
28 (4) Symbicort
AstraZeneca
6.95% Stats
29 (1) Lyrica
2.12% Stats
30 (3) Suboxone
4.93% Stats
31 Zetia
Merck
1.72% Stats
32 (4) Diovan
Novartis Pharmaceuticals Corporation
-4.00% Stats
33 (1) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc.
1.26% Stats
34 (1) Flovent HFA
GlaxoSmithKline
-1.59% Stats
35 (4) Lidoderm
Endo Pharmaceuticals Inc.
4.21% Stats
36 (4) Lovaza
GlaxoSmithKline
6.39% Stats
37 (1) Remicade
Janssen Pharmaceuticals, Inc.
1.76% Stats
38 (3) Benicar
Daiichi Sankyo
1.38% Stats
39 (5) Restasis
Allergan plc
8.67% Stats
40 (3) Dexilant
Takeda Pharmaceutical Company Limited
3.33% Stats
41 (5) Diovan HCT
Novartis Pharmaceuticals Corporation
16.21% Stats
42 (3) OxyContin
Purdue Pharma LP
0.16% Stats
43 (4) Vytorin
Merck
-2.41% Stats
44 (4) VESIcare
Astellas Pharma US, Inc.
2.37% Stats
45 (4) Celebrex
3.70% Stats
46 (4) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
4.58% Stats
47 (5) Niaspan
AbbVie Inc.
6.23% Stats
48 (5) Enbrel
Amgen Inc.
13.33% Stats
49 (2) Janumet
Merck
0.92% Stats
50 (4) Evista
9.62% Stats
51 (15) Actos
Takeda Pharmaceutical Company Limited
-46.64% Stats
52 () EpiPen 2-Pak
n/a Stats
53 (2) TriCor
AbbVie Inc.
6.11% Stats
54 (5) Cialis
Eli Lilly and Company
7.76% Stats
55 (1) Vyvanse
Takeda Pharmaceutical Company Limited
-2.60% Stats
56 (1) Aciphex
Eisai Inc.
-2.37% Stats
57 (1) methylphenidate
Generic
-2.19% Stats
58 (2) amphetamine/dextroamphetamine
Generic
3.95% Stats
59 (3) Humira
AbbVie Inc.
7.56% Stats
60 (5) Rebif
EMD Serono, Inc.
11.36% Stats
61 Epogen
Amgen Inc.
-3.04% Stats
62 (2) Truvada
Gilead Sciences, Inc.
0.52% Stats
63 Rituxan
Genentech, Inc.
-3.30% Stats
64 (5) Victoza
Novo Nordisk
18.08% Stats
65 (23) Lipitor
-63.30% Stats
66 Atripla
Gilead Sciences, Inc.
-0.42% Stats
67 Avastin
Genentech, Inc.
-0.84% Stats
68 Viagra
1.56% Stats
69 (1) Seroquel XR
AstraZeneca
-0.46% Stats
70 (1) modafinil
Generic
-0.25% Stats
71 (8) Varivax
Merck
33.68% Stats
72 (2) Lunesta
Sunovion Pharmaceuticals Inc.
2.40% Stats
73 (2) Orencia
Bristol-Myers Squibb Company
1.52% Stats
74 (2) Adderall XR
Takeda Pharmaceutical Company Limited
-11.90% Stats
75 (2) Neulasta
Amgen Inc.
-1.19% Stats
76 (2) Renvela
Sanofi
7.48% Stats
77 () Sensipar
Amgen Inc.
n/a Stats
78 () Xolair
n/a Stats
79 (3) Procrit
Janssen Pharmaceuticals, Inc.
-7.59% Stats
80 (2) Reyataz
Bristol-Myers Squibb Company
-1.08% Stats
81 (1) Aranesp
Amgen Inc.
-3.55% Stats
82 (2) Isentress
Merck
2.76% Stats
83 (3) Copaxone
Teva Pharmaceuticals USA, Inc.
9.78% Stats
84 () Gardasil
Merck
n/a Stats
85 (2) Prezista
Janssen Pharmaceuticals, Inc.
0.91% Stats
86 (2) Lucentis
Genentech, Inc.
n/a Stats
87 () Zostavax
Merck
n/a Stats
88 (1) Alimta
Eli Lilly and Company
-2.67% Stats
89 (1) Neupogen
Amgen Inc.
n/a Stats
90 (2) Herceptin
Genentech, Inc.
-0.61% Stats
91 Prevnar 13
Pfizer Inc.
-5.39% Stats
92 (2) Zyvox
Pfizer Inc.
-8.51% Stats
93 (12) Eloxatin
Sanofi
-54.45% Stats
94 (1) Avonex
Biogen
-6.82% Stats
95 (1) Gleevec
Novartis Pharmaceuticals Corporation
9.52% Stats
96 (1) Xeloda
Genentech, Inc.
-1.52% Stats
97 (1) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
6.78% Stats
98 (1) Gilenya
Novartis Pharmaceuticals Corporation
12.24% Stats
99 () Stelara
Janssen Pharmaceuticals, Inc.
n/a Stats
100 Incivek
Vertex Pharmaceuticals Incorporated
-18.18% Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.